Tat-mediated p66shc transduction decreased phosphorylation of endothelial nitric oxide synthase in endothelial cells

Korean Journal of Physiology and Pharmacology

Volumn 16, Issue 3, 2012, Pages 199-204

  Lee, Sang Ki ^a   Lee, Ji Young ^a   Joo, Hee Kyoung ^a   Cho, Eun Jung ^a   Kim, Cuk Seong ^a   Lee, Sang Do ^a   Park, Jin Bong ^a   Jeon, Byeong Hwa ^a  

^a Chungnam National University   (South Korea)

Author keywords

Endothelial cells; Endothelial nitric oxide synthase; p66shc; Superoxide; Tat mediated transduction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYBRID PROTEIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P66; SUPEROXIDE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84864003765     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2012.16.3.199     Document Type: Article

References (29)

1. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, SupertiFurga G, Pawson T, Di Fiore PP, Lanfrancone L, Pelicci PG. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 1997;16:706-716. (Pubitemid 27089518)
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-1478. (Pubitemid 39302636)
3. Molavi B, Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol. 2004;19:488493.
4. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vase Biol. 2005;25:29-38. (Pubitemid 40054251)
5. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA. 2003;100:2112-2116. (Pubitemid 36254582)
6. Kim CS, Son SJ, Kim EK, Kim SN, Yoo DG, Kim HS, Ryoo SW, Lee SD, Irani K, Jeon BH. Apurinic/apyrimidinic endonucleasel/redox factor-1 inhibits monocyte adhesion in endothelial cells. Cardiovasc Res. 2006;69:520-526. (Pubitemid 43098808)
7. Kawashima S. Malfunction of vascular control in lifestylerelated diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis. J Pharmacol Sci. 2004;96:411-419. (Pubitemid 40144061)
8. Martin-Padura I, de Nigris F, Migliaccio E, Mansueto G, Minardi S, Rienzo M, Lerman LO, Stendardo M, Giorgio M, De Rosa G, Pelicci PG, Napoli C. p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice. Endothelium. 2008;15:276-287.
9. Camici GG, Schiavoni M, Francia P, Bachschmid M, MartinPadura I, Hersberger M, Tanner FC, Pelicci P, Volpe M, Anversa P, Lüscher TF, Cosentino F. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA. 2007;104:5217-5222. (Pubitemid 47186202)
10. Yamamori T, White AR, Mattagajasingh I, Khanday FA Haile A Qi B, Jeon BH, Bugayenko A Kasuno K, Berkowitz DE, Irani K. P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction. J MoI Cell Cardiol. 2005;39:992-995. (Pubitemid 41572332)
11. Lee SK, Chung JI, Park MS, Joo HK, Lee EJ, Cho EJ, Park JB, Ryoo S, Irani K, Jeon BH. Apurinic/apyrimidinic endonuclease 1 inhibits protein kinase C-mediated p66shc phosphorylation and vasoconstriction. Cardiovasc Res. 2011;91:502-509.
12. Lee SK, Kim HS, Song YJ, Joo HK, Lee JY, Lee KH, Cho EJ, Cho CH, Park JB, Jeon BH. Alteration of p66shc is associated with endothelial dysfunction in the abdominal aortic coarctation of rats. FEBS Lett. 2008;582:2561-2566.
13. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods. 2001;24: 247-256. (Pubitemid 32846431)
14. Song YJ, Lee JY, Joo HK, Kim HS, Lee SK, Lee KH, Cho CH, Park JB, Jeon BH. Tat-APE1/ref-1 protein inhibits TNF-alphainduced endothelial cell activation. Biochem Biophys Res Commun. 2008;368:68-73.
15. Lee JY, Park KS, Cho EJ, Joo HK, Lee SK, Lee SD, Park JB, Chang SJ, Jeon BH. Human HOXA5 homeodomain enhances protein transduction and its application to vascular inflammation. Biochem Biophys Res Commun. 2011;410:312-316.
16. Angkeow P, Deshpande SS, Qi B, Liu YX, Park YC, Jeon BH, Ozaki M, Irani K. Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis. Cell Death Differ. 2002;9:717-725. (Pubitemid 34778038)
17. Wender PA Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA. 2000;97: 13003-13008.
18. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Lüscher TF, Volpe M, Cosentino F. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 2004;110:28892895.
19. Wu Z, Rogers B, Kachi S, Hackett SF, Sick A Campochiaro PA Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol. 2006;209:996-1005. (Pubitemid 44665722)
20. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev. 2003;8: 71-86. (Pubitemid 36342291)
21. Kim DD, Sánchez FA Durán RG, Kanetaka T, Durán WN. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol. 2007;292:H2131-2137. (Pubitemid 47084591)
22. Cho EJ, Park MS, Kim SS, Kang G, Choi S, Lee YR, Chang SJ, Lee KH, Lee SD, Park JB, Jeon BH. Vasorelaxing activity of ulmus davidiana ethanol extracts in rats: activation of endothelial nitric oxide synthase. Korean J Physiol Pharmacol. 2011;15:339-344.
23. Shin W, Cuong TD, Lee JH, Min B, Jeon BH, Lim HK, Ryoo S. Arginase inhibition by ethylacetate extract of caesalpinia sappan lignum contributes to activation of endothelial nitric oxide synthase. Korean J Physiol Pharmacol. 2011;15:123-128.
24. Lee SK, Kim YS, Kim CS, Son SJ, Yoo DG, Lee KH, Lee SD, Park JB, Jeon BH. p66shc adaptor protein suppresses the activation of endothelial nitric oxide synthase in mouse embryonic fibroblasts. Korean J Physiol Pharmacol. 2006;10: 155-159. (Pubitemid 44083789)
25. Grethe S, Ares MP, Andersson T, Pörn-Ares MI. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res. 2004;298:632-642. (Pubitemid 38950878)
26. Yu JH, Kim CS, Yoo DG, Song YJ, Joo HK, Kang G, Jo JY, Park JB, Jeon BH. NADPH oxidase and mitochondrial ROS are involved in the TNF-alpha-induced vascular cell adhesion molecule-1 and monocyte adhesion in cultured endothelial cells. Korean J Physiol Pharmacol. 2006;10:217-222. (Pubitemid 44377448)
27. Li G, Barrett EJ, Barrett MO, Cao W, Liu Z. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Endocrinology. 2007;148:3356-3363. (Pubitemid 46996990)
28. Zhang XH, Yokoo H, Nishioka H, Fujii H, Matsuda N, Hayashi T, Hattori Y. Beneficial effect of the oligomerized polyphenol oligonol on high glucose-induced changes in eNOS phosphorylation and dephosphorylation in endothelial cells. Br J Pharmacol. 2010;159:928-938.
29. Xing F, Jiang Y, Liu J, Zhao K, Mo Y, Liu Z, Zeng Y. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation. Biochem Cell Biol. 2006;84:780-788. (Pubitemid 46121603)